Atypical gynecomastia mimicking breast malignancy on mammography, sonography, and 18F-fluciclovine PET/CT in the setting of biochemical recurrence of prostate cancer.
18F-fluciclovine breast uptake
atypical gynecomastia
male breast mass
Journal
The breast journal
ISSN: 1524-4741
Titre abrégé: Breast J
Pays: United States
ID NLM: 9505539
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
15
03
2020
accepted:
18
03
2020
pubmed:
8
4
2020
medline:
22
6
2021
entrez:
8
4
2020
Statut:
ppublish
Résumé
A 60-year-old man with metastatic prostate cancer presented with breast swelling for one year. Suspicious breast masses were identified in both breasts with mammography and ultrasound. Biopsy of both masses showed florid gynecomastia without malignancy. Sixteen months later, the patient underwent 18F-fluciclovine PET/CT for biochemical recurrence of prostate cancer; this showed focal radiotracer uptake in both breasts. Repeat mammogram and ultrasound showed these areas to correspond with the previously biopsied masses, which were stable. To our knowledge, this is the first reported case of gynecomastia mimicking malignancy on 18F-fluciclovine PET/CT.
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1805-1807Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Nguyen C, Kettler MD, Swirsky ME, et al. Male breast disease: pictorial review with radiologic-pathologic correlation. Radiographics. 2013;33(3):763-779.
Guise TA, Oefelein MG, Eastham JA, Cookson MS, Higano CS, Smith MR. Estrogenic side effects of androgen deprivation therapy. Rev Urol. 2007;9(4):163-180.
Gusman M, Aminsharifi JA, Peacock JG, Anderson SB, Clemenshaw MN, Banks KP. Review of 18F-fluciclovine PET for detection of recurrent prostate cancer. Radiographics. 2019;39(3):822-841.
Mcconathy J. 18F-Fluciclovine (FACBC) and its potential use for breast cancer imaging. J Nucl Med. 2016;57(9):1329-1330.
Tade FI, Cohen MA, Styblo TM, et al. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of breast cancer: an exploratory study. J Nucl Med. 2016;57(9):1357-1363.